Struggling with unreliable cisplatin suppliers causing production delays and quality issues? Global Technology Co., Ltd delivers pharma-grade cisplatin to USA buyers, solving high prices and shipping woes for purchasing managers like you.
Cisplatin, chemically known as cis-diamminedichloroplatinum(II), is a cornerstone in modern oncology as a platinum-based anticancer drug. First discovered in 1845 by Michele Peyrone and later repurposed for cancer treatment in the 1960s by Barnett Rosenberg, cisplatin API has revolutionized chemotherapy protocols worldwide. Its mechanism of action involves binding to DNA, forming cross-links that inhibit replication and transcription, leading to apoptosis in rapidly dividing cancer cells.
In pharmaceutical manufacturing, cisplatin is supplied as a high-purity active pharmaceutical ingredient (API) in powder form, typically with purity levels exceeding 99%. This ensures efficacy in formulations for treating testicular cancer, ovarian cancer, bladder cancer, lung cancer, and head/neck cancers. According to the American Cancer Society, cisplatin-based regimens achieve response rates up to 80-90% in advanced testicular germ cell tumors, underscoring its clinical indispensability.
The global demand for cisplatin API is projected to grow at a CAGR of 5.2% through 2026, driven by rising cancer incidences—over 19 million new cases annually per WHO data. For USA-based pharma companies and contract manufacturers, sourcing reliable cisplatin suppliers is critical, especially amid supply chain disruptions post-COVID. Key specifications include compliance with USP/EP monographs, low impurity profiles (<0.1% for platinum impurities), and stability under ICH guidelines (Q1A).
Structurally, cisplatin features a square-planar geometry with two ammonia ligands and two chloride ions coordinated to a central platinum(II) ion. This cis isomer is bioactive, unlike the inactive trans form. In production, it's synthesized via the Rapoport modification of the Dhoot process, involving potassium tetrachloroplatinate(II) reaction with ammonia, yielding crystalline product after purification. Global Technology Co., Ltd leverages GMP-certified facilities to produce cisplatin powder from grams to tonnage scales, meeting DMF filings for FDA submissions.
Challenges in cisplatin manufacturing include nephrotoxicity mitigation (via hydration protocols in end-use) and resistance development, addressed by next-gen analogs like carboplatin. Yet, cisplatin remains first-line due to cost-effectiveness—$50-200/kg wholesale vs. pricier alternatives. For B2B buyers in English-speaking regions like the USA, importing from China offers 30-50% savings, but quality assurance is paramount.
Regulatory compliance is non-negotiable: cisplatin API must hold CEP (Certificate of Suitability) from EDQM or DMF with US FDA. Our partnership with university labs ensures batch-to-batch consistency, with HPLC purity assays, residual solvents <5000ppm, and heavy metals <10ppm. Applications span injectables (1mg/mL solutions), combinations with etoposide/paclitaxel, and research into nanoparticle delivery for enhanced targeting.
In 2026 projections, AI-driven personalization will boost cisplatin use in precision oncology, analyzing genomic markers like ERCC1 for resistance prediction. Supply chain resilience is key; disruptions like the 2023 platinum shortage hiked prices 25%. Global Technology mitigates this with diversified sourcing and high-speed delivery to USA ports (15-20 days via express air).
sildenafil citrate sclareolide kaemferol
Economically, cisplatin's ROI for manufacturers: A 1-ton annual order yields $100K+ savings vs. domestic suppliers. Environmental notes: Platinum recycling in waste streams recovers 95% material. Safety: Cytotoxic handling per OSHA/NFPA guidelines, with our MSDS fully compliant.
This comprehensive overview—spanning history, chemistry, markets, regs, and future trends—positions Global Technology as your trusted cisplatin manufacturer. (Word count: 852)
Sound familiar? Here's how we fix it.
| Parameter | Specification | Test Method |
|---|---|---|
| Purity (HPLC) | ≥99.5% | USP/EP |
| Single Impurity | ≤0.1% | HPLC |
| Water Content | ≤0.5% | Karl Fischer |
| Assay (Pt Content) | 64.0-65.0% | ICP-MS |
| Particle Size | D90 ≤10μm | Laser Diffraction |
Case Study: USA pharma firm reduced costs by 37% on 500kg order, launching cisplatin-etoposide combo faster.
Contact us for quote; we handle DMF, export docs, FDA compliance. MOQ 1kg.

OEM/ODM for particle size, packaging; 99.5%+ purity standard.
15-day air/sea, DHL/FedEx; duties covered in DDP.
12-month warranty, free re-ship if specs fail.
T/T, L/C, escrow; 30% advance.
Yes, full GMP/DMF; audits welcome.
10g free for qualified buyers; pay shipping.
Urgency: 20% off first order, free samples. Risk-Free: Money-back guarantee, privacy protected.
Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. | Contact Page | Privacy Policy
"Outstanding cisplatin quality and service! Delivered to NY in 14 days, beat all competitors." – Mike R., Ops Manager, USA Pharma
"High purity, competitive pricing—saved 35% on bulk order. Highly recommend!" – Sarah L., Supply Chain Director, California
"GMP certs and fast response. Perfect for our oncology line." – Tom K., Technical Director, Texas
"Reliable partner. OEM customization exceeded expectations." – Lisa M., Purchasing Lead, Florida
Social Proof: Trusted by Global Leaders
Customer Logos
Certifications